Search - tctmd.com

Displaying 221 - 240 of 611

Sort: Relevancy | Date

News Conference News TCT 2021

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

Todd Neale

November 03, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for October 2021

Shelley Wood

November 02, 2021

News Daily News

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

Caitlin E. Cox

October 26, 2021

News Opinion Off Script

Restarting In-Person Interventional Meetings: A Delicate but Necessary Juggling Act

Juan F. Granada, MD

October 14, 2021

News Conference News VIVA 2021

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

L.A. McKeown

October 12, 2021

News Daily News

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Caitlin E. Cox

October 11, 2021

News Conference News VIVA 2021

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

L.A. McKeown

October 08, 2021

News Conference News VIVA 2021

Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms

L.A. McKeown

October 07, 2021

News Conference News VIVA 2021

Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis

L.A. McKeown

October 06, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for September 2021

Shelley Wood

October 01, 2021

News Daily News

Long-term Anticoagulation After Unprovoked VTE: New Insights

Shelley Wood

September 13, 2021

News Daily News

TCTMD’s Top 10 Most Popular Stories for August 2021

Shelley Wood

September 03, 2021

News Conference News ESC 2021

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

Michael O'Riordan

August 29, 2021

News Opinion Editor's Corner ESC 2021

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Shelley Wood

August 19, 2021

News Daily News

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

L.A. McKeown

August 10, 2021

News Daily News

PAD Continues to Elude Clinicians, Despite Gains: AHA

L.A. McKeown

August 05, 2021

News Industry News

Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic™ Endovascular System

August 04, 2021

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for July 2021

Shelley Wood

August 02, 2021

News CV Team Pro

Keith Tottenham

L.A. McKeown

June 23, 2021

News Daily News

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

Todd Neale

June 23, 2021

Advertisement

FlowTriever Safe, Effective for Acute PE in Expanded FLASH Results

TCTMD’s Top 10 Most Popular Stories for October 2021

Predictors of AF May Help Guide Care After Stroke of Unknown Cause

Restarting In-Person Interventional Meetings: A Delicate but Necessary Juggling Act

EMINENT: Better Patency With DES Over BMS for Fem-Pop Lesions

Rivaroxaban Again Linked to More Bleeding vs Other DOACs

Diverting or Swirling, New Blood-Flow Tech Shows Promise for CLTI

Striking Racial Gaps Exist in Care for Peripheral Interventions, Registry Affirms

Vascular Care Falls Short Before Amputation for CLI: Medicare Analysis

TCTMD’s Top 10 Most Popular Stories for September 2021

Long-term Anticoagulation After Unprovoked VTE: New Insights

TCTMD’s Top 10 Most Popular Stories for August 2021

Massive SSaSS Study Shows Switch to Salt Substitute Cuts Stroke, CVD

ESC 2021: Trials, Guidelines, and Channel Surfing at This Year’s Virtual Congress

Rivaroxaban Safe, Effective in Renal Disease: VOYAGER PAD

PAD Continues to Elude Clinicians, Despite Gains: AHA

Boston Scientific Initiates Randomized Controlled Trial for the EkoSonic™ Endovascular System

TCTMD’s Top 10 Most Popular Stories for July 2021

Keith Tottenham

SUNSET sPE: Ultrasound Doesn’t Boost Catheter-Directed Thrombolysis for PE

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content